Zheng Fan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Mesenchymal Stem Cells

Top Venues

The EMBO journal

Bioinformatics (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Weiwei Li, Zepeng Xu, Tianhui Niu, Yufeng Xie, Zhennan Zhao, Dedong Li, Qingwen He, Wenqiao Sun, Kaiyuan Shi, Wenjing Guo, Zhen Chang, Kefang Liu, Zheng Fan, Jianxun Qi, George Fu Gao
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins. The EMBO journal 43 (8) (2024)
Weiwei Li, Zepeng Xu, Tianhui Niu, Yufeng Xie, Zhennan Zhao, Dedong Li, Qingwen He, Wenqiao Sun, Kaiyuan Shi, Wenjing Guo, Zhen Chang, Kefang Liu, Zheng Fan, Jianxun Qi, George Fu Gao
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins. The EMBO journal 43 (8) (2024)
Weiwei Li, Zepeng Xu, Tianhui Niu, Yufeng Xie, Zhennan Zhao, Dedong Li, Qingwen He, Wenqiao Sun, Kaiyuan Shi, Wenjing Guo, Zhen Chang, Kefang Liu, Zheng Fan, Jianxun Qi, George Fu Gao
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins. The EMBO journal (2024)
Weiwei Li, Zepeng Xu, Tianhui Niu, Yufeng Xie, Zhennan Zhao, Dedong Li, Qingwen He, Wenqiao Sun, Kaiyuan Shi, Wenjing Guo, Zhen Chang, Kefang Liu, Zheng Fan, Jianxun Qi, George Fu Gao
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins. The EMBO journal 43 (8) (2024)
Bin Huang, Tingwen Fan, Kaiyue Wang, Haicang Zhang, Chungong Yu, Shuyu Nie, Yangshuo Qi, Wei-Mou Zheng, Jian Han, Zheng Fan, Chuncui Huang, Sheng Ye, Huaiyi Yang, Dongbo Bu
Accurate and efficient protein sequence design through learning concise local environment of residues. Bioinformatics (Oxford, England) 39 (3) (2023)